生化检测对糖尿病肾病早期临床诊断的临床价值分析  

The Clinical Value of Biochemical Detection in the Early Diagnosis of Diabetic Nephropathy

作　　者：王华磊[1] WANG Hua-lei(Department of Laboratory Medicine,Zhaoyuan Center for Disease Control and Prevention,Yantai,Shandong Province,265400 China)

机构地区：[1]山东省招远市疾病预防控制中心检验科,山东烟台265400

出　　处：《糖尿病新世界》2020年第17期57-58,61,共3页Diabetes New World Magazine

摘　　要：目的探究生化检测对糖尿病肾病早期临床诊断的临床价值。方法选取该院2018年2月—2019年2月收治的82例糖尿病肾病早期患者为研究组,另选同期健康体检者82名为对照组,分别对两组进行血尿素氮(BUN)、肌酐(Cr)、视黄醇结合蛋白(RBP)、血胱抑素C(CysC)等生化指标检测,分析各项指标对糖尿病肾病早期临床诊断的临床价值。结果研究组检测指标水平均高于对照组,差异有统计学意义(P<0.05);CysC+RBP+Cr+BUN联合检测阳性率为95.1%,均高于单项指标阳性率,差异有统计学意义(P<0.05)。结论对于糖尿病肾病患者及早进行相应的指标检测,采取有效的措施,改善预后。Objective To explore the clinical value of biochemical detection for early clinical diagnosis of diabetic nephropathy.Methods 82 case with early diabetic nephropathy admitted in the hospital in February 2018 and February 2019 were selected as the study group,and 82 peple with healthy physical examination during the same period were selected as the control group.The two groups were treated with blood urea nitrogen(BUN),Creatinine(Cr),retinol-binding protein(RBP),blood cystatin C(CysC)and other biochemical indicators,analyze the clinical value of each indicator in the early clinical diagnosis of diabetic nephropathy.Results The detection index level of the study group was higher than that of the control group,and the difference was statistically significant(P<0.05);the positive rate of CysC+RBP+Cr+BUN combined detection was 95.1%,which was higher than the positive rate of individual indicators,and the difference was statistically significant(P<0.05).Conclusion For patients with diabetic nephropathy,carry out corresponding index detection as soon as possible,and take effective measures to improve the prognosis.

关 键 词：生化检测 糖尿病肾病早期 临床价值 临床应用 

分 类 号：R59[医药卫生—内科学]